Patient receives the first CryoValve SG heart valve
The first CryoValve SG pulmonary human heart valve, manufactured by CryoLife, has been received by the first patient. The product was approved by the FDA in February and is used in replacing the malfunctioning native pulmonary valves in patients. Children with congenital heart defects can also receive the valve for right ventricular outflow tract reconstruction procedures.
-
FDA approves new trauma device
Medtronic wins advisory panel backing for Melody heart valve
FDA Approves Melody Valve
FDA approves Edwards’ Perimount Magna mitral valve
CardiAQ Valve Technologies To Present Latest In Vivo Results Of Its Transcatheter Mitral Valve Implantation System At TCT 2010
